Alex Rosenberg is the founder of Parse Biosciences. Parse Biosciences has raised $50M in total funding. Latest round: Series C. Based in Seattle, USA.
Alex Rosenberg is a co-founder of Parse Biosciences, a Seattle biotech startup specializing in single-cell sequencing. The company was founded in 2021 as a spin-out from the University of Washington. Parse Biosciences recently secured $50 million in Series C funding to support its continued growth.
Full founder directory · Investor directory · Company funding database · Fundraising library